Literature DB >> 19178391

Intravitreal bevacizumab for choroidal neovascularization secondary to choroidal osteoma.

Won Kyung Song1, Hyoung Jun Koh, Oh Woong Kwon, Suk Ho Byeon, Sung Chul Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19178391     DOI： 10.1111/j.1600-0420.2007.01136.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  11 in total

1.  Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization.

Authors:  Farhad Fazel Najafabadi; Seyyed Moien Hendimarjan; Yasaman Zarrin; Mohammadreza Fazel Najafabadi
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec

2.  Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.

Authors:  Andrea Saitta; Michele Nicolai; Piergiorgio Neri; Michele Reibaldi; Alfonso Giovannini; Cesare Mariotti
Journal:  Int Ophthalmol       Date:  2015-03-12       Impact factor: 2.031

3.  Intravitreally injected ranibizumab versus photodynamic therapy for CNV secondary to choroidal osteoma: a 7-year follow-up case report.

Authors:  Li-Yuan Rong; Li Ran; Shi-Ying Li; Xiao-Hong Meng; Yan-Ling Long; Hai-Wei Xu
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

Review 4.  Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature.

Authors:  Silvio Polizzi; Vinit B Mahajan
Journal:  J Ocul Pharmacol Ther       Date:  2015-08-24       Impact factor: 2.671

Review 5.  Intravitreal anti-vascular endothelial growth factor medications during pregnancy: current perspective.

Authors:  Morteza Naderan; Masomeh Sabzevary; Keivan Rezaii; Ali Banafshehafshan; Seddigheh Hantoushzadeh
Journal:  Int Ophthalmol       Date:  2020-10-12       Impact factor: 2.031

6.  Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma.

Authors:  Mariko Kubota-Taniai; Toshiyuki Oshitari; Maya Handa; Takayuki Baba; Jiro Yotsukura; Shuichi Yamamoto
Journal:  Clin Ophthalmol       Date:  2011-07-27

7.  Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma.

Authors:  Zenith H Y Wu; Michelle Y Y Wong; Timothy Y Y Lai
Journal:  Case Rep Ophthalmol       Date:  2012-06-12

8.  Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma.

Authors:  Tadanobu Yoshikawa; Kanji Takahashi
Journal:  Clin Ophthalmol       Date:  2015-03-03

9.  Photodynamic therapy combined with intravitreal bevacizumab in a patient with choroidal neovascularization secondary to choroidal osteoma.

Authors:  Jung Hyun Jang; Keong Hwan Kim; Soo Jung Lee; Jung Min Park
Journal:  Korean J Ophthalmol       Date:  2012-11-12

10.  Bilateral choroidal osteoma with choroidal neovascular membrane treated with bevacizumab in a child.

Authors:  Manisha Agarwal; Meha Kantha; Rahul Mayor; Ramesh Venkatesh; Cyrus M Shroff
Journal:  Middle East Afr J Ophthalmol       Date:  2014 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.